Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00530335 · COMPLETED

Trial details

NCT number: NCT00530335
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2007-09-01
Primary completion: 2008-04-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.